Chemoprevention of colorectal cancer

Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2006, Vol 23, Issue 6

Abstract

Colorectal cancer is among the leading causes of cancer-related deaths. Surgical resection combined with the use of evolving chemotherapeutic agents remains the only curative treatment, and the likelihood of cure is greater when the disease is detected at an earlier histological stage. Early detection is the goal of screening programs that use periodic examination of stool for occult blood and endoscopic examination of the bowel. An alternative approach to reducing mortality from colorectal cancer involves the long-term use of a variety of oral agents that can prevent neoplasms from developing. Such pharmacologic prevention, known as chemoprevention, is directed at preventing the development of adenomatous polyps and their subsequent progression to colorectal cancer. Recent observations suggest a number of potential targets for chemoprevention. Many agents promise potential benefit, but show only modest chemopreventive efficacy in clinical trials. The inhibition of the growth of pre-cancerous and cancerous cells without damage to normal cells is the ultimate aim of cancer treatment, and is of particular importance in chemoprevention studies, which may be long term in nature, involve healthy subjects and cause minimal toxicity. Cancer prevention is certain to be a significant focus of research and intervention in the coming years, propelled by the realization that it will become possible to identify both the individuals susceptible to specific cancers and the molecular targets that can alter or stop the carcinogenesis process. Pharmacologists and geneticists are collaborating to develop new chemoprevention agents designed to act on molecular targets linked to specific pre-malignant or predisposing conditions.

Authors and Affiliations

M. Karamouzis, A. Papavassiliou

Keywords

Related Articles

Plasmodium falciparum malaria; megaloblastic anemia (folic acid deficiency)

A 42-year-old woman was admitted to the hospital, because of persistent fever and severe anemia. The patient first presented fever approximately 30 days before her admission. Since then, she presented spikes of high t...

Diagnostic quality. Likelihoods

The clinical usefulness of a diagnostic test (laboratory test or clinical finding) is determined by the discriminating ability of the test, meaning its ability to correctly classify patients with or without a specified...

The association of vitamin B12 levels with gastroscopy findings and H. pylori status in adults attending an out-patient gastroenterology clinic

OBJECTIVE To evaluate the correlation of Helicobacter pylori status with the blood levels of vitamin B12 in patients undergoing gastroendoscopic investigation. METHOD Patients who underwent gastroendoscopic investigat...

Damage control surgery

During the past 20 years, it gradually became apparent that the results of prolonged and extensive surgical procedures in the critically injured patient were often poor, even in experienced hands. The triad of hypothermi...

Download PDF file
  • EP ID EP133937
  • DOI -
  • Views 45
  • Downloads 0

How To Cite

M. Karamouzis, A. Papavassiliou (2006). Chemoprevention of colorectal cancer. Αρχεία Ελληνικής Ιατρικής, 23(6), 547-559. https://europub.co.uk/articles/-A-133937